Literature DB >> 18846334

Effects of tanshinone IIA on transforming growth factor beta1-Smads signal pathway in renal interstitial fibroblasts of rats.

Jinhui Tang1, Chengye Zhan, Jianhua Zhou.   

Abstract

The effects of tanshinone IIA (TSN) on transforming growth factor beta1 (TGFbeta1) signal transduction in renal interstitial fibroblasts of rats were studied in order to investigate its mechanism in prevention of renal interstitial fibrosis. Rat renal fibroblasts of the line NRK/49F were cultured in vitro, stimulated with 5 ng/mL TGFbeta1 and pretreated with 10(-6), 10(-5), 10(-4) mol/L TSN respectively. The mRNA levels of fibronectin (FN) were examined by RT-PCR. The protein expression of FN and Smads was detected by Western blot. TGFbeta1 induced the expression of FN mRNA and Smads in a time-dependent manner in a certain range. Compared with pre-stimulation, the FN mRNA and protein levels were increased by 1.1 times and 1.5 times respectively (P<0.01, P<0.01), and the protein expression of phosphorylated Smad2/3 (p-Smad2/3) increased by 7 times at the end of TGFbeta1 stimulation (P<0.01). TSN pretreatment may down-regulate the FN and p-Smad2/3 expression in a dose-dependent manner. 10(-6) mol/L TSN pretreatment had no effect on the FN and p-Smad2/3 expression (both P>0.05). After pretreatment with 10(-5) and 10(-4) mol/L TSN, the FN mRNA levels were decreased by 28.1% and 43.8% respectively (P<0.05, P<0.01), the FN protein levels were decreased by 40% and 44% respectively (P<0.05, P<0.05), and the p-Smad2/3 protein expression were decreased by 40% and 65% respectively (P<0.05, P<0.01). The inhibitory effect of TSN on renal interstitial fibrosis may be related to its blocking effect on TGFbeta1-Smads signal pathway in renal interstitial fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18846334     DOI: 10.1007/s11596-008-0511-0

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  12 in total

Review 1.  Angiotensin II, TGF-beta and renal fibrosis.

Authors:  J Gaedeke; H Peters; N A Noble; W A Border
Journal:  Contrib Nephrol       Date:  2001       Impact factor: 1.580

Review 2.  Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease.

Authors:  P J Stahl; D Felsen
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 3.  Role of matrix metalloproteinases in renal pathophysiologies.

Authors:  J M Catania; G Chen; A R Parrish
Journal:  Am J Physiol Renal Physiol       Date:  2006-12-26

Review 4.  Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation.

Authors:  Franck Verrecchia; Alain Mauviel
Journal:  J Invest Dermatol       Date:  2002-02       Impact factor: 8.551

Review 5.  Renal fibrosis: new insights into the pathogenesis and therapeutics.

Authors:  Youhua Liu
Journal:  Kidney Int       Date:  2006-01       Impact factor: 10.612

6.  Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK1/2 and p38 MAPK.

Authors:  Kei Kiribayashi; Takao Masaki; Takayuki Naito; Takahiko Ogawa; Takafumi Ito; Noriaki Yorioka; Nobuoki Kohno
Journal:  Kidney Int       Date:  2005-03       Impact factor: 10.612

Review 7.  Cellular and molecular pathways that lead to progression and regression of renal fibrogenesis.

Authors:  Hirokazu Okada; Raghu Kalluri
Journal:  Curr Mol Med       Date:  2005-08       Impact factor: 2.222

Review 8.  Fibronectin fibrillogenesis, a cell-mediated matrix assembly process.

Authors:  Yong Mao; Jean E Schwarzbauer
Journal:  Matrix Biol       Date:  2005-09       Impact factor: 11.583

Review 9.  Mechanisms of tubulointerstitial fibrosis.

Authors:  Masayuki Iwano; Eric G Neilson
Journal:  Curr Opin Nephrol Hypertens       Date:  2004-05       Impact factor: 2.894

Review 10.  TGF-beta signaling and the fibrotic response.

Authors:  Andrew Leask; David J Abraham
Journal:  FASEB J       Date:  2004-05       Impact factor: 5.191

View more
  11 in total

1.  The effect of tanshinone IIA upon the TGF-beta1/Smads signaling pathway in hypertrophic myocardium of hypertensive rats.

Authors:  Yongsheng Li; Yuping Yang; Dan Yu; Qiansheng Liang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-08-07

2.  Pentoxifylline inhibits liver fibrosis via hedgehog signaling pathway.

Authors:  Hui Li; Juan Hua; Chun-Xia Guo; Wei-Xian Wang; Bao-Ju Wang; Dong-Liang Yang; Ping Wei; Yin-Ping Lu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

3.  The Chinese medicine, Jianpi Huayu Decoction, inhibits the epithelial mesenchymal transition via the regulation of the Smad3/Smad7 cascade.

Authors:  Chong Zhong; Yong-Fa Zhang; Jun-Hai Huang; Zi-Yu Wang; Qiu-Yuan Chen; Li-Tian Su; Zhen-Tao Liu; Cheng-Ming Xiong; Zhi Tao; Rong-Ping Guo
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

4.  Sodium Tanshinone IIA Sulfonate Ameliorates Bladder Fibrosis in a Rat Model of Partial Bladder Outlet Obstruction by Inhibiting the TGF-β/Smad Pathway Activation.

Authors:  Xiaoxiao Jiang; Yaping Chen; Haitao Zhu; Bo Wang; Ping Qu; Renfu Chen; Xiaoqing Sun
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

5.  Effects of tanshinone IIA on the transforming growth factor β1/Smad signaling pathway in rat cardiac fibroblasts.

Authors:  Cheng-Ye Zhan; Jin-Hui Tang; Dai-Xing Zhou; Zhi-Hui Li
Journal:  Indian J Pharmacol       Date:  2014 Nov-Dec       Impact factor: 1.200

6.  Rescue therapy with Tanshinone IIA hinders transition of acute kidney injury to chronic kidney disease via targeting GSK3β.

Authors:  Chunming Jiang; Wei Zhu; Xiang Yan; Qiuyuan Shao; Biao Xu; Miao Zhang; Rujun Gong
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

7.  Tanshinone IIA attenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation.

Authors:  Xia Chen; Rui Wu; Yiwei Kong; Yuting Yang; Yu Gao; Dandan Sun; Qizhen Liu; Dongjun Dai; Zeyuan Lu; Niansong Wang; Sheng Ge; Feng Wang
Journal:  Oncotarget       Date:  2017-05-09

8.  Sodium Tanshinone IIA Sulfonate Prevents Radiation-Induced Toxicity in H9c2 Cardiomyocytes.

Authors:  Wenjing Zhang; Yi Li; Rui Li; Yaya Wang; Mengwen Zhu; Bowen Wang; Yanling Li; Dongyun Li; Ping Xie; Bin Liu
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-12       Impact factor: 2.629

9.  A network pharmacology approach to understanding the mechanisms of action of traditional medicine: Bushenhuoxue formula for treatment of chronic kidney disease.

Authors:  Shao-hua Shi; Yue-piao Cai; Xiao-jun Cai; Xiao-yong Zheng; Dong-sheng Cao; Fa-qing Ye; Zheng Xiang
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

10.  Tanshinone IIA Attenuates Renal Fibrosis after Acute Kidney Injury in a Mouse Model through Inhibition of Fibrocytes Recruitment.

Authors:  Chunming Jiang; Qiuyuan Shao; Bo Jin; Rujun Gong; Miao Zhang; Biao Xu
Journal:  Biomed Res Int       Date:  2015-12-29       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.